JPS63151351A - Water in oil type emulsified composition - Google Patents
Water in oil type emulsified compositionInfo
- Publication number
- JPS63151351A JPS63151351A JP61299591A JP29959186A JPS63151351A JP S63151351 A JPS63151351 A JP S63151351A JP 61299591 A JP61299591 A JP 61299591A JP 29959186 A JP29959186 A JP 29959186A JP S63151351 A JPS63151351 A JP S63151351A
- Authority
- JP
- Japan
- Prior art keywords
- water
- oil
- type
- clay mineral
- swellable clay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 13
- 239000002734 clay mineral Substances 0.000 claims abstract description 12
- 239000007762 w/o emulsion Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 abstract description 18
- 238000003756 stirring Methods 0.000 abstract description 6
- 239000008346 aqueous phase Substances 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 33
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 20
- -1 more specifically Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GWKNUVAXSQNESV-UHFFFAOYSA-N 1-decan-2-yloxypentadecane Chemical compound C(CCCCCCCCCCCCCC)OC(C)CCCCCCCC GWKNUVAXSQNESV-UHFFFAOYSA-N 0.000 description 2
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 2
- NGHUOSKIZOQGBY-PMDAXIHYSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-[2,3-bis[[(Z)-octadec-9-enoyl]oxy]propoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC NGHUOSKIZOQGBY-PMDAXIHYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000008269 hand cream Substances 0.000 description 2
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- RBMGJIZCEWRQES-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(N)=O RBMGJIZCEWRQES-DKWTVANSSA-N 0.000 description 1
- GGTYBZJRPHEQDG-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid hydrochloride Chemical compound Cl.NCCC[C@H](N)C(O)=O GGTYBZJRPHEQDG-WCCKRBBISA-N 0.000 description 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- UJZJPLFMNRLGBT-UHFFFAOYSA-N 1-octan-2-yloxydecane Chemical compound CCCCCCCCCCOC(C)CCCCCC UJZJPLFMNRLGBT-UHFFFAOYSA-N 0.000 description 1
- BTWPHTDACLVGMG-UHFFFAOYSA-N 1-octoxydecane Chemical compound CCCCCCCCCCOCCCCCCCC BTWPHTDACLVGMG-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 229940033655 asparagine monohydrate Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960003707 glutamic acid hydrochloride Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960003244 ornithine hydrochloride Drugs 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Colloid Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は化粧品や医薬品として有用な油中水型(以下W
2O型と称す。)乳化組成物に関し、更に詳しくは外相
となる油分として極性油から非極性油まで幅広く用いる
ことができ、得られた乳化組成物の温度安定性、使用性
が極めて優れているという特徴を持つ油中水型乳化組成
物に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention provides water-in-oil type (hereinafter referred to as W-type) useful as cosmetics and pharmaceuticals.
It is called type 2O. ) Regarding emulsified compositions, more specifically, oils that can be used in a wide range of oils, from polar oils to non-polar oils, as the external phase, and have the characteristics that the resulting emulsified compositions have extremely excellent temperature stability and usability. The present invention relates to a water-in-water emulsion composition.
[従来の技術]
従来W10型乳化組成物を得るには、乳化剤としてHL
B値が1〜12の親油性界面活性剤、例えばグリセリン
脂肪酸エステル、ソルビタン脂肪酸二ステル等の多価ア
ルコール脂肪酸エステル系活性剤を用い、油相に該活性
剤を0.4〜5.0g程度添加し、70〜80℃程度に
加熱溶解したのち、同程度の温度に加温した水相を添加
してホモミキサー等で攪拌してW10型乳化組成物(以
下W10型エマルションと称す。)を得ていた。[Prior art] Conventionally, in order to obtain a W10 type emulsion composition, HL was used as an emulsifier.
A lipophilic surfactant with a B value of 1 to 12, such as a polyhydric alcohol fatty acid ester active agent such as glycerin fatty acid ester or sorbitan fatty acid dister, is used, and about 0.4 to 5.0 g of the active agent is added to the oil phase. After adding and heating and dissolving at about 70 to 80°C, the aqueous phase heated to the same temperature is added and stirred with a homomixer etc. to form a W10 type emulsion composition (hereinafter referred to as W10 type emulsion). I was getting it.
[発明が解決しようとする問題点コ
しかしながら、こうして得られたW/○型エマルション
は、水中油型(以下0/W型と称する。)エマルション
に比べ、温度安定性や使用性の優れた系が得られにくい
という欠点があった。たとえば温度安定性に関しては、
低温においては水滴の凝集による連続相である油相の分
離が生じ易く、また高温では水滴の合一により粒子径が
増大し、下層へ沈降してしまい上層部が油相のみとなる
油相分離といった現象が生じ易い。一方、使用性に関し
ては外相が油分であることから、化粧品や医薬品の分野
では皮膚の保護や柔軟性の付与等の利点を有する半面、
使用時のべたつきや皮膚閉塞能が高いという欠点があっ
た。[Problems to be solved by the invention] However, the W/○ type emulsion thus obtained is a system with superior temperature stability and usability compared to oil-in-water type (hereinafter referred to as 0/W type) emulsion. The disadvantage was that it was difficult to obtain. For example, regarding temperature stability,
At low temperatures, the oil phase, which is a continuous phase, tends to separate due to the aggregation of water droplets, and at high temperatures, the particle size increases due to the coalescence of water droplets and settles to the lower layer, resulting in oil phase separation where the upper layer is only the oil phase. Such phenomena are likely to occur. On the other hand, in terms of usability, since the external phase is oil, it has advantages such as protecting the skin and imparting flexibility in the cosmetics and pharmaceutical fields.
It has the drawbacks of being sticky when used and having a high skin occluding ability.
温度安定性を改良する方法の一つとしては、油相にワッ
クスを多量に配合して粘稠性を高める方法があるが、こ
れは低温安定性は向上するが高温保存においては、配合
したワックスの軟化や融解等により、水滴の合一による
油相分離は充分に改良し得ず、のび等の使用性に関する
新たな問題が生ずるという欠点があった。One way to improve temperature stability is to increase the viscosity by blending a large amount of wax into the oil phase.This method improves low temperature stability, but during high temperature storage, the blended wax The oil phase separation caused by the coalescence of water droplets cannot be sufficiently improved due to the softening and melting of the oil, and new problems with usability such as spread arise.
このような使用性の問題点を改良する方法としては、0
/W型エマルシヨンの系でよ(用いられるエステル結合
等を有する極性油分の配合が好ましいが、従来用いられ
てきたW/○型乳型剤化剤極性油分を配合した系で安定
性の優れたW10型エマルションを生成することは困難
であった。As a method to improve such usability problems, 0
/W-type emulsion system (preferably a polar oil component having an ester bond, etc.) is used, but it is preferable to use a conventionally used W/○-type emulsion system containing a polar oil component, which has excellent stability. It was difficult to produce W10 type emulsions.
本発明者等はこうした先行技術の欠点を改良すべく鋭意
研究を重ねた結果、水膨潤性粘土鉱物と非イオン性界面
活性剤と油分と水とを必須構成成分とするW10型エマ
ルションは、非イオン性界面活性剤が比較的少量でも乳
化可能で、極性油分を配合した系でも粘稠性が高く、か
つ温度安定性が良好で滑かな使用性を与える等、優れた
Wlo型エマルションであることを見出し、この知見に
基づいて本発明を完成するに至った。The present inventors have conducted intensive research to improve the drawbacks of the prior art, and as a result, the W10 type emulsion, which has water-swellable clay minerals, nonionic surfactants, oil, and water as essential components, has been developed. It is an excellent Wlo type emulsion that can be emulsified even with a relatively small amount of ionic surfactant, has high viscosity even in systems containing polar oil, has good temperature stability, and provides smooth usability. The present invention was completed based on this finding.
[問題点を解決するための手段]
即ち本発明は、水膨潤性粘土鉱物と、非イオン性界面活
性剤と、油分と、水とを必須構成成分とする油中水型乳
化組成物を提供するものである。[Means for Solving the Problems] That is, the present invention provides a water-in-oil emulsion composition containing a water-swellable clay mineral, a nonionic surfactant, an oil, and water as essential components. It is something to do.
以下本発明の構成について述べる。The configuration of the present invention will be described below.
本発明に用いる水膨潤性粘土鉱物は、三層構造を有する
コロイド性含水ケイ酸アルミニウムの一種で、一般に下
記一般式
%式%
[[
で表され、具体的にはモンモリロナイト、サボナイトお
よびヘクトライト等の天然又は合成〔この場合、式中の
(OH)基がフッ素で置換されたもの)のモンモリロナ
イト群(市販品ではビーガム、クニビア、ラポナイト等
がある。)およびナトリウムシリシックマイカやナトリ
ウム又はリチウムテニオライトの名で知られる合成雲母
(市販品ではダイモナイト;トビーエ業(株)等がある
)等である。配合量は0.2〜5%が好適である。The water-swellable clay mineral used in the present invention is a type of colloidal hydrated aluminum silicate having a three-layer structure, and is generally represented by the following general formula % [[, and specifically, montmorillonite, savonite, hectorite, etc. Natural or synthetic (in this case, the (OH) group in the formula is substituted with fluorine) of the montmorillonite group (commercially available products include Veegum, Knivia, Laponite, etc.), sodium silicic mica, sodium or lithium tenio Synthetic mica known as Wright (commercially available products include Daimonite; manufactured by Tobie Gyo Co., Ltd., etc.). The blending amount is preferably 0.2 to 5%.
本発明に用いる非イオン性界面活性剤としては、そのH
LB値(注1)が2〜16、ざらに好適には3〜12の
非イオン性界面活性剤があげられる。As the nonionic surfactant used in the present invention, its H
Examples include nonionic surfactants having an LB value (Note 1) of 2 to 16, more preferably 3 to 12.
(注1)ノニオン活性剤のHLB値は、下式の周上式に
より算出される。(Note 1) The HLB value of the nonionic activator is calculated using the following equation.
W HL B =7+11.7・log□ O (ここでMwは親木基部の分子量、M。W HL B = 7 + 11.7・log□ O (Here, Mw is the molecular weight of the base of the parent tree, M.
は親油基部の分子量をそれぞれ表す。)具体的に例示す
れば、ポリオキシエチレン2〜30モル付加(以下P
OE (2〜30)と略す。ンオレイルエ−テ)Lt、
POE (2−35)ヌfア’)Atエ−テk、POE
(2〜20)ラウリルエーテル、P OE (1〜20
)アルキルフェニルエーテル、POE(6〜18)ベヘ
ニルエーテル、POE(5〜25)2−デシルペンタデ
シルエーテル、P OE (3〜30)2−デシルテト
ラデシルエーテル、P OE (8〜16)2−オクチ
ルデシルエーテル等のエーテル型活性剤、およびP O
E (4〜60)硬化ヒマシ油、P OE (3〜14
)脂肪酸モノエステル、P OE (6〜30)脂肪酸
ジエステル、P OE (5〜20)ソルビタン脂肪酸
エステル等のエステル型活性剤、更にP OE (2〜
30)グリセリルモノイソステアレート、POE(10
〜60)グリセリルトリイソステアレート、POE(7
〜50)硬化ヒマシ油モノインステアレート、POE(
12〜60)硬化ヒマシ油トリイソステアレート等のエ
ーテルエステル型活性剤等のエチレンオキシド付加型界
面活性剤、およびデカグリセリルテトラオレート、ヘキ
サグリセリルトリイソステアレート、テトラグリセリル
ジイソステアレート、ジグリセリルジイソステアレート
等のポリグリセリン脂肪酸エステル、グリセリルモノス
テアレート、グリセリルモノイソステアレート、グリセ
リルモノオレート等のグリセリン脂肪酸エステル、等の
多価アルコール脂肪酸エステル型界面活性剤があげられ
る。これらの中でデカグリセリルテトラオレート、ヘキ
サグリセリルトリイソステアレート、テトラグリセリル
ジイソステアレート等のトリグリセリン以上のポリグリ
セリン脂肪酸エステル、P OE (2〜12)オレイ
ルエーテル、POE(3〜12)ステアリルエーテル、
POE(2〜10)ラウリルエーテル、POE(2〜1
0)ノニルフェニルエーテル、POE(6〜15)ベヘ
ニルエーテル、P OE (5〜20)2−デシルペン
タデシルエーテル、P OE (5〜17)2−デシル
テトラデシルエーテル、P OE (8〜16)2−オ
クチルデシルエーテル等のPOE付加エーテル型活性剤
、オJ: ヒP OE (10−20)硬化ヒマシ油、
POE(5〜14)オレイン酸モノエステル、P OE
(6〜20)オレイン酸ジエステル、POE(5〜1
0)ソルビタンオレイン酸エステル等のPOE付加エス
テル型活性剤、POE(3〜15)グリセリルモノイソ
ステアレート、P OE (10〜40)グリセリルト
リイソステアレート等のPOE付加エーテルエステル型
活性剤等のエチレンオキシド付加型の非イオン性界面活
性剤が特に好ましい。represents the molecular weight of the lipophilic group, respectively. ) To give a specific example, addition of 2 to 30 moles of polyoxyethylene (hereinafter P
Abbreviated as OE (2-30). Lt.
POE (2-35) nu f a') At aet k, POE
(2-20) lauryl ether, P OE (1-20
) Alkylphenyl ether, POE (6-18) behenyl ether, POE (5-25) 2-decyl pentadecyl ether, P OE (3-30) 2-decyl tetradecyl ether, P OE (8-16) 2- Ether-type activators such as octyl decyl ether, and P O
E (4-60) Hydrogenated castor oil, P OE (3-14
) fatty acid monoester, P OE (6-30) fatty acid diester, P OE (5-20) ester type activator such as sorbitan fatty acid ester, and further P OE (2-
30) Glyceryl monoisostearate, POE (10
~60) Glyceryl triisostearate, POE (7
~50) Hydrogenated castor oil monoinstearate, POE (
12-60) Ethylene oxide-added surfactants such as ether ester type surfactants such as hydrogenated castor oil triisostearate, and decaglyceryl tetraoleate, hexaglyceryl triisostearate, tetraglyceryl diisostearate, diglyceryl diisostearate, etc. Examples include polyhydric alcohol fatty acid ester type surfactants such as polyglycerin fatty acid esters such as isostearate, glycerin fatty acid esters such as glyceryl monostearate, glyceryl monoisostearate, and glyceryl monooleate. Among these, polyglycerin fatty acid esters higher than triglycerin such as decaglyceryl tetraoleate, hexaglyceryl triisostearate, and tetraglyceryl diisostearate, POE (2-12) oleyl ether, POE (3-12) stearyl ether,
POE (2-10) lauryl ether, POE (2-1
0) Nonylphenyl ether, POE (6-15) Behenyl ether, P OE (5-20) 2-decyl pentadecyl ether, P OE (5-17) 2-decyl tetradecyl ether, P OE (8-16) POE addition ether type activator such as 2-octyl decyl ether, OJ: HPOE (10-20) hydrogenated castor oil,
POE (5-14) oleic acid monoester, POE
(6-20) Oleic acid diester, POE (5-1
0) POE-added ester type activators such as sorbitan oleate, POE-added ether ester-type activators such as POE (3-15) glyceryl monoisostearate, POE (10-40) glyceryl triisostearate, etc. Particularly preferred are ethylene oxide-added nonionic surfactants.
本発明に用いる非イオン性界面活性剤のもうひとつのタ
イプとしては下記一般式
%式%)
携
を
士
呂
二 冗 帷 渣t
→咥ミ
こ)
二一一−α −
=
で表されるポリエーテル変性シリコン化合物等があげら
れ、特に油がシリコン油又はシリコン油を含有する油で
ある場合に好適である。Another type of nonionic surfactant used in the present invention is the following general formula (%).
→ Mouth Miko) Polyether-modified silicone compounds represented by 211-α − = are mentioned, and are particularly suitable when the oil is silicone oil or an oil containing silicone oil.
本発明の実施にあたってはこれら非イオン性界面活性剤
の中から一種または二種以上が任意に選択されて用いら
れる。配合量は水膨潤性粘土鉱物に対して0.05〜2
倍量が好ましい。In carrying out the present invention, one or more of these nonionic surfactants may be arbitrarily selected and used. The blending amount is 0.05 to 2 for the water-swellable clay mineral.
Double doses are preferred.
本発明に用いられる油分は化粧品、医薬品等で用いられ
る一般的な油分は全て用いることができ、その範囲も極
性油から非極性油まで幅広く用いることができる。油分
を例示すれば、流動パラフィン、スクワラン、イソパラ
フィン、分岐鎖状軽パラフィン等の炭化水素油、イソプ
ロピルミリステート、セチルイソオクタノエート、グリ
セリルトリオクタノエート等のエステル油、デカメチル
シクロペンタシロキサン、ジメチルポリシロキサン、メ
チルフェニルポリシロキザン等のシリコーン油等が挙げ
られる。又ワセリン、マイクロクリスタリン、ラノリン
、ピースワックス、等のワックス類も本発明の効果を損
なわない範囲で配合可能である。これら油分の配合量は
W10型エマルション中、5〜90重量%程度であり、
10〜80重量%が好ましい。The oil used in the present invention can be any of the common oils used in cosmetics, pharmaceuticals, etc., and can be used in a wide range from polar oils to non-polar oils. Examples of oils include hydrocarbon oils such as liquid paraffin, squalane, isoparaffin, and branched light paraffins, ester oils such as isopropyl myristate, cetyl isooctanoate, and glyceryl trioctanoate, decamethylcyclopentasiloxane, Examples include silicone oils such as dimethylpolysiloxane and methylphenylpolysiloxane. Further, waxes such as vaseline, microcrystalline, lanolin, peace wax, etc. can also be incorporated within the range that does not impair the effects of the present invention. The blending amount of these oils is about 5 to 90% by weight in the W10 emulsion,
10 to 80% by weight is preferred.
本発明のW10型エマルションには必要に応じて本発明
の効果を損なわない範囲で、アミノ酸及びその塩、保湿
剤、増粘剤、防腐剤、金属イオン封鎖剤、紫外線吸収剤
、薬剤、動植物抽出物等の天然エキス、分散剤、香料等
を配合することができる。The W10 type emulsion of the present invention may contain amino acids and their salts, humectants, thickeners, preservatives, sequestering agents, ultraviolet absorbers, drugs, animal and plant extracts, as necessary, to the extent that the effects of the present invention are not impaired. Natural extracts, dispersants, fragrances, etc. can be added.
上記アミノ酸を例示するとアラニン、アルギニン塩酸塩
、アスパラギン1水和物、アスパラギン酸、シトルリン
、グルタミン酸、グルタミン酸塩酸塩、グルタミン、グ
リシン、ヒスチジン、ヒスチジン塩酸塩、ハイドロキシ
プロリン、イソロイシン、ロイシン、リジン、リジン塩
酸塩、オルニチン塩酸塩、プロリン、フェニルアラニン
、セリン、スレオニン、トリプトファン、チロシン、バ
リン、ドーパ−1αアミノ酪酸等である。これらは、L
一体、D一体、及びDL一体からなる。Examples of the above amino acids include alanine, arginine hydrochloride, asparagine monohydrate, aspartic acid, citrulline, glutamic acid, glutamic acid hydrochloride, glutamine, glycine, histidine, histidine hydrochloride, hydroxyproline, isoleucine, leucine, lysine, and lysine hydrochloride. , ornithine hydrochloride, proline, phenylalanine, serine, threonine, tryptophan, tyrosine, valine, dopa-1α aminobutyric acid, and the like. These are L
It consists of one piece, one piece D, and one piece DL.
これらの中で、特に好ましいのは、グリシン、L−ハイ
ドロキシプロリン、L−アラニン、L−プロリン、L−
セリンで、これらと塩を生成する金属は、ナトリウム、
カリウム、リヂウム、カルシウム、マグネシウム等があ
る。Among these, particularly preferred are glycine, L-hydroxyproline, L-alanine, L-proline, and L-
The metals that form salts with serine are sodium,
Potassium, lithium, calcium, magnesium, etc.
本発明の油中水型乳化組成物を製造するには、例えば、
水膨潤性粘土鉱物と油分と非イオン性界面活性剤とを7
0℃程度に加熱撹拌混合し、これに水相を添加し撹拌し
て得る方法、油分と非イオン性界面活性剤とを約70℃
で加熱混合し、これに予め水膨潤性粘土鉱物を分散膨潤
させた水相を添加、し、撹拌して得る方法等があげられ
る。To produce the water-in-oil emulsion composition of the present invention, for example,
Water-swellable clay mineral, oil and non-ionic surfactant
The oil and nonionic surfactant are mixed at about 70°C by heating and stirring at about 0°C, then adding the aqueous phase and stirring.
Examples include a method of heating and mixing, adding thereto an aqueous phase in which water-swellable clay minerals have been previously dispersed and swollen, and stirring.
[発明の効果]
本発明のW10型エマルションは、通常の乳化剤と水膨
潤性粘土鉱物との複合的なW10乳化作用を利用して調
製されるものであり、W10乳化剤として機能する両者
のトータル配合量は0.25〜5重量%と少なくてよく
、その配合量又は内水相の比率をコントロールすること
によってワックス等の固化剤を多量に配合することなく
粘稠性をコントロールすることが可能であり、又従来配
合することが困難であった極性の高い油分を用いること
もでき、かつ広い温度範囲にわたって優れた保存安定性
を有するものである。かかる大きな利点を有する本発明
のW10型エマルションは、その特徴を生かすことによ
って化粧品や医薬品等の広範な分野に利用可能である。[Effects of the Invention] The W10 type emulsion of the present invention is prepared by utilizing the combined W10 emulsifying action of a normal emulsifier and a water-swellable clay mineral, and the total combination of both functions as a W10 emulsifier. The amount may be as small as 0.25 to 5% by weight, and by controlling the amount or the ratio of the internal aqueous phase, it is possible to control the viscosity without adding a large amount of solidifying agent such as wax. It also allows the use of highly polar oils, which have traditionally been difficult to incorporate, and has excellent storage stability over a wide temperature range. The W10 type emulsion of the present invention, which has such great advantages, can be used in a wide range of fields such as cosmetics and pharmaceuticals by taking advantage of its characteristics.
[実施例]
次に本発明の一層の理解の為に、実施例をあげて更に詳
細に説明する。本発明はこれによって限定されるもので
はない。例中、部、%、とあるのは全て重量部、重量%
である。[Example] Next, in order to further understand the present invention, the present invention will be described in more detail by giving examples. The present invention is not limited thereby. In examples, parts and % are all parts by weight and % by weight.
It is.
実施例1 モイスチャークリーム
(1)スクワラン 20.0(2
)セチルイソオクタノエート 8.5(3)ワ
セリンP1.5
(4) POE (12)ジオレート260(5)香料
適量(6)パラオキシ安
息香酸エチル 0.2(7)ヒアルロン酸ナトリ
ウム 0.01(8)グリセリン
10.0(’l) 1 、3−ブチレンゲ
リコール 5.0(10)ビーガム
1.5(11)精製水
残余(製法)(1)〜(6)を混合分散し、
あらかじめ油相を調製しておく。次に(7)〜(11)
を均一に溶解したものを徐々にディスパーで撹拌しなが
ら油相に添加し目的のモイスチャークリームを得た。Example 1 Moisture cream (1) Squalane 20.0 (2
) Cetyl isooctanoate 8.5 (3) Vaseline P1.5 (4) POE (12) Diolet 260 (5) Fragrance appropriate amount (6) Ethyl paraoxybenzoate 0.2 (7) Sodium hyaluronate 0.01 ( 8) Glycerin
10.0 ('l) 1,3-butylene gelicol 5.0 (10) Veegum
1.5 (11) Purified water
Mix and disperse the remainder (manufacturing method) (1) to (6),
Prepare the oil phase in advance. Next (7) to (11)
A uniformly dissolved solution was gradually added to the oil phase while stirring with a disperser to obtain the desired moisture cream.
実施例2 ハンドクリーム
、(1)ジメチルポリシロキサン 30.0(
平均重合度=9)
(2)流動パラフィン 10.0(3
)マイクロクリスタリンワックス 2.0(4)ポリ
エーテル変性シリコン化合物 3.0(一般式Aの構造
を有し、ポリ
オキシエチレン基を20重足置
含有し、平均分子量が6000の
もの)
(5)バラヒドロキシ安息香酸ブチル 0.1(6)
グリセリン 20.0(7)サボ
ナイト 2.0(8)精製水
残余(製法) 実施例1に準
じて目的のハンドクリームを得た。Example 2 Hand cream, (1) dimethylpolysiloxane 30.0 (
Average degree of polymerization = 9) (2) Liquid paraffin 10.0 (3
) Microcrystalline wax 2.0 (4) Polyether-modified silicone compound 3.0 (having the structure of general formula A, containing 20 polyoxyethylene groups, and having an average molecular weight of 6000) (5) Butyl rose hydroxybenzoate 0.1(6)
Glycerin 20.0 (7) Savonite 2.0 (8) Purified water
Residue (manufacturing method) A target hand cream was obtained according to Example 1.
実施例3 化粧下地クリーム
(1)スクワラン 23.0(2
)デカメチルシクロペンタ
シロキサン 5.0(3)マイク
ロクリスタリンワックス 2.0(4)ポリエーテル
変性シリコン化合物 1.0(一般式Aの構造を有し、
ポリ
オキシエチレン基を20重量%
含有し、平均分子鼠が6000の
もの)
(5)ジグリセリルジイソステアレート1.0(6)パ
ラヒドロキシ安息香酸ブチル 0.1(7)香料
適量(8)酸化チタン
i、。Example 3 Makeup base cream (1) Squalane 23.0 (2
) Decamethylcyclopentasiloxane 5.0 (3) Microcrystalline wax 2.0 (4) Polyether-modified silicone compound 1.0 (having the structure of general formula A,
(5) Diglyceryl diisostearate 1.0 (6) Butyl parahydroxybenzoate 0.1 (7) Fragrance
Appropriate amount (8) Titanium oxide
i.
(9)着色顔131 o、
t(10)ジプロピレングリコール 5.0(
11)クニビア 2.5(11
)水 残余(製法)
実施例1に準じて目的の化粧下地クリームを1蔓た。(9) Colored face 131 o,
t(10) dipropylene glycol 5.0(
11) Knibia 2.5 (11
) Water Remaining (manufacturing method) According to Example 1, one batch of the desired makeup base cream was prepared.
次に実施例1乃至3の粘度及び安定性の試験績・安定性
0:分離が全く見られない
Δ:液相(油相又は水相)の分離が生じたX:著しい液
相の分離が生じたNext, test results of viscosity and stability of Examples 1 to 3: Stability 0: No separation observed Δ: Separation of liquid phase (oil phase or water phase) occurred X: Significant separation of liquid phase occured
Claims (1)
油分と、水とを必須構成成分とする油中水型乳化組成物
。(1) A water-swellable clay mineral, a nonionic surfactant,
A water-in-oil emulsion composition containing oil and water as essential components.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61299591A JP2517254B2 (en) | 1986-12-16 | 1986-12-16 | Water-in-oil cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61299591A JP2517254B2 (en) | 1986-12-16 | 1986-12-16 | Water-in-oil cream |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63151351A true JPS63151351A (en) | 1988-06-23 |
JP2517254B2 JP2517254B2 (en) | 1996-07-24 |
Family
ID=17874616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61299591A Expired - Fee Related JP2517254B2 (en) | 1986-12-16 | 1986-12-16 | Water-in-oil cream |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2517254B2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0383909A (en) * | 1989-08-28 | 1991-04-09 | Mikimoto Seiyaku Kk | Cosmetic and its production |
JPH0820529A (en) * | 1994-07-06 | 1996-01-23 | Shiseido Co Ltd | Water-in-oil emulsified composition |
WO1998023251A1 (en) * | 1996-11-27 | 1998-06-04 | The Procter & Gamble Company | Mascara compositions having improved wear and beauty benefits |
JPH10330211A (en) * | 1997-05-29 | 1998-12-15 | Lion Corp | Skin cosmetic |
JPH11130613A (en) * | 1997-10-28 | 1999-05-18 | Pola Chem Ind Inc | Water-in-oil emulsified skin preparation for external use |
JP2000016941A (en) * | 1998-06-26 | 2000-01-18 | Lion Corp | Prophylatic against pollinosis |
WO2003049707A1 (en) * | 2001-12-12 | 2003-06-19 | L'oreal | Oil-in-water emulsion containing water-swellable clay mineral and use thereof |
WO2003049708A1 (en) * | 2001-12-12 | 2003-06-19 | L'oreal | Oil-in-water emulsion containing hydrophobic pigment dispersed and use thereof |
EP2301522A1 (en) * | 2010-02-12 | 2011-03-30 | Shiseido Co., Ltd. | Water-in-oil emulsion-type cosmetic preparation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781827A (en) * | 1980-09-15 | 1982-05-22 | Unilever Nv | Oil industrial water type emulsion |
JPS59127646A (en) * | 1982-12-24 | 1984-07-23 | Kobayashi Kooc:Kk | Preparation of w/o/w type emulsion |
JPS6128439A (en) * | 1984-07-18 | 1986-02-08 | Shiseido Co Ltd | Liquid emulsifier composition |
-
1986
- 1986-12-16 JP JP61299591A patent/JP2517254B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781827A (en) * | 1980-09-15 | 1982-05-22 | Unilever Nv | Oil industrial water type emulsion |
JPS59127646A (en) * | 1982-12-24 | 1984-07-23 | Kobayashi Kooc:Kk | Preparation of w/o/w type emulsion |
JPS6128439A (en) * | 1984-07-18 | 1986-02-08 | Shiseido Co Ltd | Liquid emulsifier composition |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0383909A (en) * | 1989-08-28 | 1991-04-09 | Mikimoto Seiyaku Kk | Cosmetic and its production |
JPH0820529A (en) * | 1994-07-06 | 1996-01-23 | Shiseido Co Ltd | Water-in-oil emulsified composition |
WO1998023251A1 (en) * | 1996-11-27 | 1998-06-04 | The Procter & Gamble Company | Mascara compositions having improved wear and beauty benefits |
AU726314B2 (en) * | 1996-11-27 | 2000-11-02 | Noxell Corporation | Mascara compositions having improved wear and beauty benefits |
JPH10330211A (en) * | 1997-05-29 | 1998-12-15 | Lion Corp | Skin cosmetic |
JPH11130613A (en) * | 1997-10-28 | 1999-05-18 | Pola Chem Ind Inc | Water-in-oil emulsified skin preparation for external use |
JP2000016941A (en) * | 1998-06-26 | 2000-01-18 | Lion Corp | Prophylatic against pollinosis |
WO2003049707A1 (en) * | 2001-12-12 | 2003-06-19 | L'oreal | Oil-in-water emulsion containing water-swellable clay mineral and use thereof |
WO2003049708A1 (en) * | 2001-12-12 | 2003-06-19 | L'oreal | Oil-in-water emulsion containing hydrophobic pigment dispersed and use thereof |
EP2301522A1 (en) * | 2010-02-12 | 2011-03-30 | Shiseido Co., Ltd. | Water-in-oil emulsion-type cosmetic preparation |
EP2301522A4 (en) * | 2010-02-12 | 2013-07-03 | Shiseido Co Ltd | Water-in-oil emulsion-type cosmetic preparation |
Also Published As
Publication number | Publication date |
---|---|
JP2517254B2 (en) | 1996-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5015469A (en) | Water-in-oil emulsion type cosmetics | |
JPH10513179A (en) | Roll-on antiperspirant composition | |
WO1999025310A1 (en) | Water-in-oil emulsifier composition | |
JPH048104B2 (en) | ||
JP2009013125A (en) | Emulsified cosmetic for hairdressing use | |
JP2009019023A (en) | Hair-dressing emulsified cosmetic | |
JPS63151351A (en) | Water in oil type emulsified composition | |
JPS61129033A (en) | Water in oil emulsifier composition | |
JP3417649B2 (en) | Sunscreen cosmetics | |
JP2004175736A (en) | Composition for cleansing | |
JPH08217618A (en) | Water-in-oil type emulsified cosmetic | |
JPWO2020149162A1 (en) | Lecithin-containing cosmetic base and cosmetics containing it | |
JP3424770B2 (en) | Water-in-oil emulsion composition | |
JP2004059526A (en) | Water-in-oil type emulsifying cosmetic | |
JPH07100356A (en) | New conjugate material and emulsifying agent | |
JP2003095845A (en) | Translucent liquid cosmetic | |
JPH05246821A (en) | Emulsion composition | |
JPS61209035A (en) | Polyhydric alcohol in oil type emulsion composition | |
JPH043253B2 (en) | ||
JPH03223208A (en) | Hair-treatment agent composition | |
JPH06287107A (en) | Gel-like emulsion cosmetic | |
JPH0462775B2 (en) | ||
JPS62110742A (en) | Water in oil type emulsified composition | |
JPH11116433A (en) | Water-in-oil type emulsified composition and preparation for external use for skin | |
JPH09169618A (en) | Emulsified composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |